Preclinical biotechnology company developing precision immunology therapies for autoimmune and chronic inflammatory diseases
Preclinical biotechnology company developing precision immunology therapies for autoimmune and chronic inflammatory diseases. Its approach aims to identify genetically predisposed, at-risk patients and enable earlier treatment rather than relying on trial-and-error treatment of advanced disease.